Unlock instant, AI-driven research and patent intelligence for your innovation.

A method for identifying anti-tumor lymphocytes

A lymphocyte and identification method technology, applied in animal cells, vertebrate cells, blood/immune system cells, etc., can solve the problems of failure to achieve overall satisfactory results, time-consuming, and difficulties in cancer treatment

Active Publication Date: 2016-05-25
杭州赫思缇生物科技有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no effective way to deal with cancer, especially the treatment of advanced cancer patients
Since the 20th century, the three conventional weapons of surgery, radiotherapy and chemotherapy have made great contributions to treatment and rehabilitation, but these traditional treatment methods have their limitations, and have failed to achieve overall satisfactory results in cancer treatment
This classic method of identifying tumor-killing lymphocytes is time-consuming and requires tumor cells as target cells
It is very difficult to induce and culture primary tumor cells from tumor tissues of cancer patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for identifying anti-tumor lymphocytes
  • A method for identifying anti-tumor lymphocytes
  • A method for identifying anti-tumor lymphocytes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] A 0.5 cm tumor mass and its adjacent normal breast tissue mass were surgically resected from a breast cancer patient (patient code LMC5130). In the biosafety cabinet, the tumor tissue was cut into 1 mm square tumor tissue pieces with a scalpel, and the breast normal tissue was also cut into 1 mm square normal tissue pieces. Put the tumor tissue and breast normal tissue in a 24-well culture plate, place a small piece of tumor tissue or normal tissue in each well, and culture each sample in 4 wells. Normal breast tissues were labeled 5130N-1, 5130N-2, 5130N-3, and 5130N-4; breast tumor tissues were labeled 5130Tu-1, 5130Tu-2, 5130Tu-3, and 5130Tu-4. Add 1 ml RPMI-1640 medium and 1000 IU interleukin-2 to each well. Place the 24-well culture plate at 37°C and 5% CO 2 cultured in an incubator. After two days of culture, 1 ml of RPMI-1640 medium and 200 IU of interleukin-2 were added to each well. Place the 24-well culture plate at 37°C and 5% CO 2 Continue to grow in th...

Embodiment 2

[0028] A 0.5 cm tumor mass and its adjacent normal lung tissue mass were surgically resected from a lung cancer patient (patient code LMC576). In a biosafety cabinet, the tumor tissue was cut into small pieces of 1 mm square tumor tissue with a scalpel, and the normal lung tissue was also cut into small pieces of normal tissue of 1 mm square. Place tumor tissue and normal lung tissue in a 24-well culture plate, place a small piece of tumor tissue or normal tissue in each well, and culture each sample in 4 wells. Normal lung tissues were labeled 576N-1, 576N-2, 576N-3 and 576N-4; lung cancer tumor tissues were labeled 576Tu-1, 576Tu-2, 576Tu-3 and 576Tu-4. Add 1 ml RPMI-1640 medium and 1000 IU interleukin-2 to each well. Place the 24-well culture plate at 37°C and 5% CO 2 cultured in an incubator. After two days of culture, 1 ml of RPMI-1640 medium and 200 IU of interleukin-2 were added to each well. Place the 24-well culture plate at 37°C and 5% CO 2 Continue to grow in t...

Embodiment 3

[0031]A 0.5 cm tumor mass and its adjacent normal renal tissue mass were surgically resected from a kidney cancer patient (patient code LMC584). In a biosafety cabinet, the tumor tissue was cut into small pieces of 1 mm square tumor tissue with a scalpel, and the normal kidney tissue was also cut into small pieces of normal tissue of 1 mm square. Put the tumor tissue and normal kidney tissue in a 24-well culture plate, place a small piece of tumor tissue or normal tissue in each well, and culture each sample in 4 wells. Normal kidney tissues were labeled 584N-1, 584N-2, 584N-3, and 584N-4; kidney cancer tumor tissues were labeled 584Tu-1, 584Tu-2, 584Tu-3, and 584Tu-4. Add 1 ml RPMI-1640 medium and 1000 IU interleukin-2 to each well. Place the 24-well culture plate at 37°C and 5% CO 2 cultured in an incubator. After two days of culture, 1 ml of RPMI-1640 medium and 200 IU of interleukin-2 were added to each well. Place the 24-well culture plate at 37°C and 5% CO 2 Continu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for identifying anti-tumor lymphocytes. The identification method comprises the following steps: stimulating lymphocytes of a small tumor tissue, which is taken from a cancer patient, in a specific culture medium and cultivating for 5 days; detecting the level of gamma interferon in the culture medium directly by adopting an enzyme-linked immunoassay method so as to identify the tumor killer lymphocytes. The method can directly measure the level of gamma interferon in the culture medium, is quick and low in time consumption.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a method for identifying anti-tumor lymphocytes. Background technique [0002] Environmental pollution and genetic factors can cause mutations in DNA and genes. Cancer cells originate from the uncontrolled growth of cells in the human body due to DNA mutations and damage. Usually, cancer cells grow to form a tumor, and the cancer cells will migrate to other places to continue to grow, thereby destroying normal tissues and organs, resulting in the death of the patient. [0003] Cancer has become common disease, frequently-occurring disease. According to statistics in 2008, there were 12.66 million new cancer cases and 8 million deaths in the world. It is estimated that by 2015, the number of new cancer cases will reach 15 million. "2012 China Cancer Registration Annual Report" was released, reporting that one person is diagnosed with cancer every 6 minutes nationwide, 8,550 people become...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/0783G01N33/68
CPCG01N33/6866G01N2333/57
Inventor 周菊华
Owner 杭州赫思缇生物科技有限公司